Among the neurological diseases associated with defects in RNA editing, the pathogenic roles of A-to-I RNA editing dysfunction in the GluA2 Q/R site due to the downregulation of ADAR2 have been extensively demonstrated in sporadic ALS, as described in the next section [36,71]. This evidence concerns the gene ADARB1 and amyotrophic lateral sclerosis.